INTRODUCTION
Fostriecin (1) is a phosphate monoester produced by Streptomyces pulveraceus 1 that displays promising antitumor activity. 2 It has entered NCIsponsored clinical trials, but the studies were discontinued due to its storage instability and unpredictable chemical purity. 2 In this context, more stable derivatives of fostriecin (2 and 3) have been proposed in order to evaluate the cytotoxic activity and try to understand the molecular requirements for inhibition of protein phosphatase.
RESULTS AND DISCUSSION
The synthesis of 2 and 3 began with the preparation of lactone (±)-8 in 52% yield over 6 steps (Scheme 1).
Scheme 1. Synthesis of lactone 8.
Lactone (±)-8 was converted into diastereoisomers 9a and 9b under Sharpless asymmetric dihydroxylation conditions. Subsequently, oxidation of the primary alcohol provided methyl ketones 10a and 10b, which were separated using preparative HPLC (Scheme 2).
Scheme 2. Synthesis of intermediates 10a and 10b.
The desired compounds 2 and 3 were formed after aldol condensation reaction with transcinnamaldehyde in 67% yield.
Scheme 2. Synthesis of compounds 1 and 2.
The cytotoxic activity of 2 and 3 and the synthetic intermediates 8, 9 and 10 were evaluated by cell viability assay, using PC-03 (prostate) cell lines. These cell lines are resistant to cisplatin 3 and overexpress low molecular weight protein tyrosine phosphatases (LMW-PTPs), acting as positive tumor regulator. 
